| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.8 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as problematic, has been found in X3 CMS up to 0.4.0.3. Affected by this issue is some unknown functionality. The manipulation of the argument Password leads to cross site scripting. This vulnerability is traded as CVE-2011-5255. It is possible to initiate the attack remotely. There is no exploit available.
Details
A vulnerability was found in X3 CMS up to 0.4.0.3 (Content Management System). It has been rated as problematic. This issue affects an unknown functionality. The manipulation of the argument password with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
Multiple cross-site scripting (XSS) vulnerabilities in admin/login in X3 CMS 0.4.3.1 and earlier allow remote attackers to inject arbitrary web script or HTML via the (1) PATH_INFO, (2) username, or (3) password parameter.
The weakness was shared 01/31/2013 (Website). The advisory is shared at archives.neohapsis.com. The identification of this vulnerability is CVE-2011-5255 since 01/30/2013. The attack may be initiated remotely. No form of authentication is needed for a successful exploitation. It demands that the victim is doing some kind of user interaction. Technical details are known, but no exploit is available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at X-Force (72279), SecurityFocus (BID 51346†), OSVDB (78220†) and Secunia (SA46748†). Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 3.8
VulDB Base Score: 4.3
VulDB Temp Score: 3.8
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Unproven
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
OpenVAS ID: 803403
OpenVAS Name: X3 CMS Multiple cross-site scripting (XSS) vulnerabilities
OpenVAS File: 🔍
OpenVAS Family: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
01/10/2012 🔍01/10/2012 🔍
01/30/2013 🔍
01/31/2013 🔍
01/31/2013 🔍
03/24/2015 🔍
02/04/2018 🔍
Sources
Advisory: archives.neohapsis.comStatus: Confirmed
Confirmation: 🔍
CVE: CVE-2011-5255 (🔍)
GCVE (CVE): GCVE-0-2011-5255
GCVE (VulDB): GCVE-100-63449
X-Force: 72279 - X3 CMS login.php cross-site scripting
SecurityFocus: 51346
Secunia: 46748 - X3 CMS Two Cross-Site Scripting Vulnerabilities, Less Critical
OSVDB: 78220
Entry
Created: 03/24/2015 12:22Updated: 02/04/2018 10:52
Changes: 03/24/2015 12:22 (55), 02/04/2018 10:52 (7)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.